8.53
0.12 (1.43%)
| Penutupan Terdahulu | 8.41 |
| Buka | 8.35 |
| Jumlah Dagangan | 5,024 |
| Purata Dagangan (3B) | 21,818 |
| Modal Pasaran | 312,964,000 |
| Harga / Jualan (P/S) | 38.30 |
| Harga / Buku (P/B) | 28.87 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 26 Feb 2025 - 3 Mar 2025 |
| Margin Operasi (TTM) | -2,585.09% |
| EPS Cair (TTM) | -5.05 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -9.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 58.68% |
| Nisbah Semasa (MRQ) | 0.960 |
| Aliran Tunai Operasi (OCF TTM) | -69.19 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -40.90 M |
| Pulangan Atas Aset (ROA TTM) | -195.55% |
| Pulangan Atas Ekuiti (ROE TTM) | -697.51% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (AU) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | ANTERIS CDI 1:1 [AVR] | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -0.50 |
|
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis - a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 10.51% |
| % Dimiliki oleh Institusi | 39.60% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |